Use of the proton pump inhibitor (PPI) pantoprazole does not cut the risk of upper gastrointestinal events but may reduce the risk of bleeding from gastroduodenal lesions in patients on low-dose anticoagulants and/or antiplatelet therapy, a study has shown.
In the management of supragastric belching (SGB) with cognitive behavioural therapy (CBT), factors such as number of SGB and hypervigilance score at baseline as well as proficiency during treatment help predict CBT outcomes, according to a study.
Anti-tumour necrosis factor α (anti-TNFα) agents are better than other conventional therapies at preventing the clinical, endoscopic and histological postoperative recurrence of Crohn’s disease, reports a recent meta-analysis.
Consumption of aronia berry polyphenols enhances endothelial function and regulates gut microbiota composition in men, reports a study. This shows that eating aronia berries regularly may help maintain cardiovascular health in individuals at low risk of cardiovascular disease (CVD).
For children with mild-to-moderate Crohn’s disease (CD), a CD exclusion diet (CDED) combined with partial enteral nutrition (PEN) is more tolerable than exclusive enteral nutrition (EEN), a recent study has found.
The combination of metformin, nystatin, linagliptin, rivaroxaban and a high-protein diet is the main cause of nasoenteral tube obstruction, with corresponding odds ratios of 2.0, 3.1, 4.3, 2.4 and 1.9, according to a recent study.
Proton pump inhibitor therapy, particularly with pantoprazole, does not reduce upper gastrointestinal bleeding events in patients taking low-dose anticoagulation/aspirin treatment, reports a recent study.
There appears to be an increase in inpatient incidence and mortality for gastrointestinal bleeding (GIB) related to percutaneous coronary intervention (PCI), particularly among older patients, a recent study has found.